Sensor Validation and Diagnostic Potential of Smartwatches in Movement Disorders.
Parkinson’s disease
artificial intelligence
movement disorders
smartwatches
Journal
Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366
Informations de publication
Date de publication:
30 Apr 2021
30 Apr 2021
Historique:
received:
21
03
2021
revised:
27
04
2021
accepted:
28
04
2021
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
8
5
2021
Statut:
epublish
Résumé
Smartwatches provide technology-based assessments in Parkinson's Disease (PD). It is necessary to evaluate their reliability and accuracy in order to include those devices in an assessment. We present unique results for sensor validation and disease classification via machine learning (ML). A comparison setup was designed with two different series of Apple smartwatches, one Nanometrics seismometer and a high-precision shaker to measure tremor-like amplitudes and frequencies. Clinical smartwatch measurements were acquired from a prospective study including 450 participants with PD, differential diagnoses (DD) and healthy participants. All participants wore two smartwatches throughout a 15-min examination. Symptoms and medical history were captured on the paired smartphone. The amplitude error of both smartwatches reaches up to 0.005 g, and for the measured frequencies, up to 0.01 Hz. A broad range of different ML classifiers were cross-validated. The most advanced task of distinguishing PD vs. DD was evaluated with 74.1% balanced accuracy, 86.5% precision and 90.5% recall by Multilayer Perceptrons. Deep-learning architectures significantly underperformed in all classification tasks. Smartwatches are capable of capturing subtle tremor signs with low noise. Amplitude and frequency differences between smartwatches and the seismometer were under the level of clinical significance. This study provided the largest PD sample size of two-hand smartwatch measurements and our preliminary ML-evaluation shows that such a system provides powerful means for diagnosis classification and new digital biomarkers, but it remains challenging for distinguishing similar disorders.
Identifiants
pubmed: 33946494
pii: s21093139
doi: 10.3390/s21093139
pmc: PMC8124167
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Innovative Medical Research Fund (Innovative Medizinische Forschung), University of Münster
ID : I-VA111809
Références
Nervenarzt. 2019 Aug;90(8):787-795
pubmed: 31309270
Nervenarzt. 2011 Dec;82(12):1604-11
pubmed: 21748456
Stud Health Technol Inform. 2020 Jun 16;270:889-893
pubmed: 32570510
BMC Neurol. 2015 Oct 09;15:192
pubmed: 26452640
Visc Med. 2020 Dec;36(6):443-449
pubmed: 33442551
Mov Disord. 2018 Jan;33(1):75-87
pubmed: 29193359
PLoS One. 2017 Dec 20;12(12):e0189161
pubmed: 29261709
Nat Rev Neurol. 2019 Aug;15(8):437-438
pubmed: 31152151
Parkinsonism Relat Disord. 2014 Jun;20(6):590-5
pubmed: 24661464
J Neurosci Methods. 2017 Apr 1;281:7-20
pubmed: 28223023
J Neurol. 2015;262(4):992-1001
pubmed: 25683763
Artif Intell Med. 2021 Jan;111:101984
pubmed: 33461684
Mov Disord. 2016 Sep;31(9):1272-82
pubmed: 27125836
Front Neurol. 2019 Jan 30;10:48
pubmed: 30761078
Front Neurosci. 2018 May 17;12:317
pubmed: 29867328
IEEE J Biomed Health Inform. 2018 Sep;22(5):1648-1652
pubmed: 29028217
Lancet Neurol. 2018 Nov;17(11):928-929
pubmed: 30287052
Entropy (Basel). 2020 May 20;22(5):
pubmed: 33286351